Forex Trading Library

StockWatch: Pfizer Sales Jump on Rival’s Errors

Name: StockWatch: Pfizer Sales Jump on Rival’s Errors
Uploaded: 2021-04-23
Channel: David Kindley
Description: Pfizer appears to be in the driver's seat in the global Covid-19 vaccine market. Their jab has demonstrated high efficacy and their sales have jumped up to $1.4 Billion.J&J reported $100 million in first-quarter sales of its Covid-19 shot.Ho

By David Kindley Last updated Feb 2, 2026 340 0

Pfizer appears to be in the driver’s seat in the global Covid-19 vaccine market. Their jab has demonstrated high efficacy and their sales have jumped up to $1.4 Billion.

J&J reported $100 million in first-quarter sales of its Covid-19 shot.

However, it is currently on hold in America while federal health regulators investigate a rare blood-clotting issue.

Is the US about to turn its back on the drugmaker?

Timestamps
– PFE 02:25
– JNJ 03:15

Pfizer

David Kindley

Market Strategist at Orbex David Kindley is a renowned fundamental analyst with over 10 years of trading experience in the financial markets. With a keen eye for macroeconomics and a special focus on trading psychology, David is passionate about helping everyday investors make informed trading decisions through his thorough research and analysis.

Stocks to Look Out For in Q2

The Week Ahead: US Stimulus Spending Comes At a Price